TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biognos AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
95
|
0
|
128 |
| Financial expenses |
0
|
0
|
2 |
| Earnings before taxes |
-859
|
-1,218
|
-1,287 |
| EBITDA |
-859
|
-1,211
|
-1,266 |
| Total assets |
2,614
|
602
|
584 |
| Current assets |
164
|
602
|
577 |
| Current liabilities |
318
|
417
|
383 |
| Equity capital |
1,325
|
184
|
201 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
50.7%
|
30.6%
|
34.4% |
| Turnover per employee |
95
|
0
|
128 |
| Profit as a percentage of turnover | -904.2% | -1005.5% | |
| Return on assets (ROA) |
-32.9%
|
-202.3%
|
-220.0% |
| Current ratio |
51.6%
|
144.4%
|
150.7% |
| Return on equity (ROE) |
-64.8%
|
-662.0%
|
-640.3% |
| Change turnover |
95
|
-128
|
-849 |
| Change turnover % |
-100%
|
-87% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.